Drugs / Platinum
Platinum
also known as
C.i. 77795 · DDP · Metallic platinum · Platina l · Platinum black · Platinum metallicum · Platinum powder · Platinum, elemental · +2 more
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05840341 | Jan 2023 → Dec 2025 | pancreatic neoplasm | Fudan University | Completed | No outcome recorded |
Also used as a comparator or background therapy in 2 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07162051 Background | Mar 2023 → Feb 2026 | hormone receptor-positive breast cancer | Xijing Hospital | Completed | No outcome recorded |
| Phase 2 | NCT02489409 Background | Oct 2015 → May 2018 | breast cancer | Xinjiang Medical University | Unknown | No outcome recorded |
Press releases naming this drug 1 release
| Date | Issuer | Release |
|---|---|---|
| 2026-04-12 | AbbVie | AbbVie Showcases Late‑Breaking Phase 2 Data for Mirvetuximab Soravtansine-gynx (ELAHERE®) in Platinum‑Sensitive Ovarian Cancer (PSOC) at SGO 2026 abbvie.com ↗ |
Evidence & citations 13 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Platinum | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02489409 ↗ |
| Known as | C.i. 77795 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1235478 ↗ |
| Known as | DDP | “DDP” NCT02489409 ↗ |
| Known as | Metallic platinum | ChEMBL registry synonym — accepted as the source's own label CHEMBL1235478 ↗ |
| Known as | Platina l | ChEMBL registry synonym — accepted as the source's own label CHEMBL1235478 ↗ |
| Known as | Platinum black | ChEMBL registry synonym — accepted as the source's own label CHEMBL1235478 ↗ |
| Known as | Platinum metallicum | ChEMBL registry synonym — accepted as the source's own label CHEMBL1235478 ↗ |
| Known as | Platinum powder | ChEMBL registry synonym — accepted as the source's own label CHEMBL1235478 ↗ |
| Known as | Platinum, elemental | ChEMBL registry synonym — accepted as the source's own label CHEMBL1235478 ↗ |
| Known as | QingyiHuaji optimized formula | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05840341 ↗ |
| Known as | standard chemotherapy | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07162051 ↗ |
| Modality | Small molecule | — CHEMBL1235478 ↗ |
| Route | Intravenous | “Platinum (DDP): 30 mg/m2, iv 3h, d1-3” NCT02489409 ↗ |